Catalys Pacific, LLC Portfolio Holdings

Catalys Pacific, LLC

  • $351 Billion
  • Q3 2025

Catalys Pacific, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $351 Billion distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Mineralys Therapeutics, Inc. with a value of $338B and Phathom Pharmaceuticals, Inc. with a value of $13.7B.

Examining the 13F form we can see an increase of $220B in the current position value, from $132B to 351B.

Catalys Pacific, LLC is based out at Tokyo, M0

Below you can find more details about Catalys Pacific, LLC portfolio as well as his latest detailed transactions.

Portfolio value $351 Billion
Healthcare: $13.7 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Mineralys Therapeutics, Inc.
-
$338 Billion 96.09% of portfolio
-
Q1 2025 Added 3.0%
$575M
$13.7 Billion 3.91% of portfolio
1,167,114
Q4 2024 Added 3.97%

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $351 Billion
  • Prior Value $132 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Catalys Pacific, LLC Portfolio

Follow Catalys Pacific, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalys Pacific, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalys Pacific, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email